AMH Conducting Study Examining Use of Unique Film in Cesarean Section Deliveries
ABINGTON, PA (November 6, 2009) — The Obstetrics and Gynecology Department of Abington Memorial Hospital is testing the use of an adhesion barrier commonly used in abdominal surgeries for use in cesarean sections. The study's objective is to determine if Seprafilm® will decrease the formation of adhesions and scar tissue and therefore reduce complications in repeated cesarean deliveries.
This randomized study is seeking pregnant women who are delivering their first babies by cesarean section and who plan on having additional children. The study, "Seprafilm® for the Prevention of Adhesions at Repeat Cesarean," is designed to follow participating patients through their second cesarean sections.
In "open" abdominal surgeries, Seprafilm® has been found to effectively decrease the formation of adhesions and scar tissue in non-obstetric patients. Seprafilm® is composed of chemically modified sugars, some of which occur naturally in the body, and resembles a 4" x 6" piece of clear cellophane wrap. It is applied to the internal stitches and dissolves within one week. Seprafilm® does not replace stitches.
Candidates for this study must be at least 18 years old, have not had a prior cesarean section or other abdominal surgery, and do not plan to have a tubal ligation at their delivery. In addition, they need to plan on delivering their baby at Abington Memorial Hospital. For more information about this study, please call 215-481-4499.
Abington Memorial Hospital is a 665-bed, acute care teaching hospital with a medical staff of more than 900 physicians and more than 5,600 employees. These professionals provide medical care and health services to residents of Bucks, Montgomery and Philadelphia counties.
A regional provider, Abington Memorial Hospital has the only Level II accredited trauma center in Montgomery County and offers highly specialized services in cardiac care, cancer care, neurosciences, orthopaedics and maternal/child health.